Cost Efficiency and Affordability:

• The chemical method significantly reduces costs compared to growth factor-based approaches, offering an economically viable solution for hepatocyte differentiation

Rapid Differentiation Timeline:

• Achieves functional hepatocyte differentiation in just 14 days, providing a time-efficient alternative to the conventional 28-day duration associated with growth factor-based methods.

Consistent and Defined Media Composition:

• The chemically defined media ensures consistency, eliminating batch-to-batch variation and providing a standardized protocol for deriving functional hepatocytes.

Clinical Viability and Safety:

• Derives hepatocytes from mesenchymal stem cells, already used in clinical settings, ensuring safety and making it a suitable candidate for clinical applications in liver failure treatment.

Alternative to Growth Factors:

• Overcomes the need for growth factors, reducing the overall complexity and cost of the differentiation process for functional hepatocytes.

Versatile Applications:

• Extends beyond liver failure treatment to include potential applications in cell-based therapeutics and in vitro drug testing, enhancing its versatility and relevance across multiple domains.